alanine transaminase

(redirected from Alanine amino transferase)
Also found in: Acronyms.

alanine transaminase

 [al´ah-nēn trans-am´ĭ-nās]
an enzyme that catalyzes the reversible transfer of an amino group from alanine to α-ketoglutarate to form pyruvate and glutamate. Normally present in many tissues and body fluids, especially in the liver, it is released into the serum as a result of tissue injury; the serum concentration is increased particularly when there is acute damage to hepatic cells, as in viral or toxic hepatitis, infectious mononucleosis, and obstructive jaundice. Called also alanine aminotransferase and glutamic-pyruvic transaminase.

al·a·nine a·mi·no·trans·fer·ase (ALT),

(al'ă-nēn a-mē'nō-tranz'fer-ās),
An enzyme transferring amino groups from l-alanine to 2-ketoglutarate, or the reverse (from l-glutamate to pyruvate); one d-alanine transaminase effects the same reaction, but using d-alanine and d-glutamate. Serum concentration is increased in viral hepatitis and myocardial infarction.

alanine transaminase

/al·a·nine trans·am·i·nase/ (trans-am´ĭ-nās) an enzyme normally present in serum and body tissues, especially in the liver; it is released into the serum as a result of tissue injury, hence the concentration in the serum may be increased in patients with acute damage to hepatic cells.

al·a·nine a·mi·no·trans·fer·ase

(ALT) (al'ă-nēn ă-mē'nō-trans'fĕr-ās)
An enzyme transferring amino groups from l-alanine to 2-ketoglutarate, or the reverse (from l-glutamate to pyruvate); serum concentration is increased in viral hepatitis and myocardial infarction.
Synonym(s): glutamic-pyruvic transaminase, serum glutamic-pyruvic transaminase.

al·a·nine a·mi·no·trans·fer·ase

(ALT) (al'ă-nēn ă-mē'nō-trans'fĕr-ās)
An enzyme transferring amino groups from l-alanine to 2-ketoglutarate, or the reverse (from l-glutamate to pyruvate); serum concentration is increased in viral hepatitis and myocardial infarction.
Synonym(s): glutamic-pyruvic transaminase, serum glutamic-pyruvic transaminase,
alanine transaminase.
References in periodicals archive ?
001) in the hepatic enzyme markers, alkaline phosphatase (ALP) alanine amino transferase (ALT) and aspartate amino transferase (AST), in treated rats with both moringa leaf and seed extracts were observed at doses; 100, 200 and 400 mg/kg by Olayemi et al.
The most significant fall in blood levels was observed with alanine amino transferase.
The alterations in the concentration of, Cholesterol, Triglycerides, High Density Lipoprotein (HDL), Alanine amino transferase (ALAT), Aspartate Amino Transferase (ASAT), Creatinine, Creatinine Kinase (CK), Alkaline Phosphatase, Bilirubin Direct, Bilirubin Total, Albumin, and Glucose were recorded in all groups.
7 mg/dL, aspartate amino transferase 364 IU/L, alanine amino transferase 150 IU/L, alkaline phospatase 71 IU/L and serum albumin 2.
After 4 weeks of daily treatment the RA groups (especially over 10 mg/kg) were found to have lower scores of hepatic fibrosis grade and decreased serum alanine amino transferase and glutamate pyruvate transferase.
At the end of this period, when compared to controls, it was found that Natrum sulphuricum 200C corrected the levels of acid phosphatase, alkaline phosphatase, aspartate amino transferase, and alanine amino transferase as well as produced an increase in glutathione levels, reduced lipid peroxidation, and reduced the level of damage caused to genes by carcinogens.
for 14 days on the level of serum glucose, total cholesterol, triglycerides, urea, uric acid, creatinine, aspartate amino transferase (AST) and alanine amino transferase (ALT) in normal and streptozotocin-induced diabetic rats were evaluated.
To understand the enzyme activities related to the protein metabolism, an attempt has been made to analyze the enzymes such as Alanine Amino Transferase (AIAT), Aspartate Amino Transferase (AAT) and Glutamate Dehydrogenase (GDH) in silkgland, bodywall and intestine of silkwarm larvae, treated with dexamethasone over control.
The activities of Aspartate Amino Transferase and Alanine Amino Transferase were enhanced over controls in all the tissues, at all the exposure spans.
0 (2320) (mg/L) Alanine amino transferase, 12 15 20 (d) U/L Hemoglobin, (e) g/L 150 160 169 Diastolic blood 10.
Cholestech Corporation (Nasdaq:CTEC) announced today that the Food and Drug Administration has granted 510(k) clearance for the company's new liver function test, alanine amino transferase (ALT).